SCYNEXIS, Inc. (SCYX) Financials

SCYX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 75.0 million 8.0 million
March 31, 2026 77.6 million 36.3 million
Dec. 31, 2025 59.0 million 9.7 million
Sept. 30, 2025 51.1 million 14.6 million

SCYX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.9 million 568000
March 31, 2026 -8.1 million 580000
Dec. 31, 2025 18.4 million 687000
Sept. 30, 2025 -8.7 million 526000

SCYX Net Income

No data available :(

SCYX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 54.1 million - 1.9 million
March 31, 2026 59.3 million 1.6 million 504000
Dec. 31, 2025 40.1 million - 2.2 million
Sept. 30, 2025 38.0 million - 1.8 million

SCYX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 11.8 million
March 31, 2026 6.4 million
Dec. 31, 2025 5.4 million
Sept. 30, 2025 6.2 million

SCYX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 3.9 million 4.1 million -
March 31, 2026 - 12.4 million 4.6 million -
Dec. 31, 2025 - 4.5 million 3.6 million -
Sept. 30, 2025 - 5.5 million 3.3 million -

SCYX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 235000 -
March 31, 2026 - -
Dec. 31, 2025 18.6 million -
Sept. 30, 2025 334000 -

SCYX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SCYX

Price: $3.84

52 week price:
3.53
9.12

Payout Ratio Range:
-0.07%
1.10%

Earnings Per Share: -0.89 USD

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 45800

Ebitda: -8.0 million

Market Capitalization: 30.4 million

Links: